Related Experiment Video
Updated: Jun 23, 2026

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Recalibration and Validation of a Risk Scoring Tool to Predict Multidrug-Resistant Pseudomonas aeruginosa
Nhu Le1, Hyunuk Seung2, Megan E Dunning3
1University of Maryland School of Medicine, Baltimore, Maryland, USA.
Abstract:
We recalibrated a risk score to identify difficult-to-treat resistant Pseudomonas aeruginosa among 197 intensive care unit patients with bloodstream or respiratory infection. Prevalence was 6%. Models showed moderate discrimination (c-statistic 0.71-0.74), low sensitivity (18%), and high specificity (94%-96%), highlighting the need for local validation and consideration of performance tradeoffs.
Insights
A new risk score helps identify difficult-to-treat resistant *Pseudomonas aeruginosa* in intensive care units. While specific, the score needs local validation due to moderate accuracy and low sensitivity for detecting this challenging bacteria.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- *Pseudomonas aeruginosa* is a significant cause of hospital-acquired infections.
- Difficult-to-treat resistant strains pose a growing clinical challenge.
- Accurate identification of resistant pathogens is crucial for effective treatment.
Purpose of the Study:
- To recalibrate and evaluate a risk score for identifying difficult-to-treat resistant *Pseudomonas aeruginosa*.
- To assess the performance of the risk score in an intensive care unit (ICU) population.
- To provide data for clinical decision-making in managing *Pseudomonas aeruginosa* infections.
Main Methods:
- Retrospective analysis of 197 ICU patients with *Pseudomonas aeruginosa* bloodstream or respiratory infections.
- Recalibration of an existing risk score.
- Evaluation of model discrimination (c-statistic), sensitivity, and specificity.
Main Results:
- The prevalence of difficult-to-treat resistant *Pseudomonas aeruginosa* was 6%.
- The recalibrated risk score demonstrated moderate discrimination (c-statistic 0.71-0.74).
- The model exhibited low sensitivity (18%) but high specificity (94%-96%).
Conclusions:
- The developed risk score shows potential for identifying difficult-to-treat resistant *Pseudomonas aeruginosa*.
- The low sensitivity necessitates caution and suggests the score is better for ruling out resistance.
- Local validation and careful consideration of performance trade-offs are essential before clinical implementation.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...